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for example, in the study of complications during preg-
nancy such as preeclampsia (Kilpatrick 1999).
The log-linear model is equivalent to a conditional
logistic analysis comparing the case to appropriately de-
fined “pseudo-sibling controls” (Kraft 2002). If the gene
under study is assumed not to play a direct role in an
individual’s risk of disease (or to be linked to any other
such gene), then to test for an indirect role of maternal
genotype (say) each case subject should be compared to
a pseudo-sibling control subject whose mother has the
genotype of the case subject’s father. That is, if the ge-
notypes of the mother and father are Gm and Gf, re-
spectively, then the conditional logistic likelihood for the
family is
bZ(G )me
,
bZ (G ) bZ(G )m fe  e
where Z(7) is some dominance coding.
This approach (reasonably) assumes that, given the
set of parental marker genotypes {G1,G2}, it is equally
likely that Gm p G1 or G2. In other words, “the fre-
quency of heterozygous mothers married to homozygous
variant fathers is the same as the frequency of hetero-
zygous fathers married to homozygous variant mothers,
and so on” (Wilcox et al. 1998). Furthermore, since this
likelihood permutes the genotypes of “the parent con-
tributing to disease risk” and the “the parent not con-
tributing to disease risk,” it cannot estimate joint effects
of both parents’ genotypes. However, for many diseases,
only the mother (father) will plausibly contribute to a
child’s disease risk.
Although the case-parent trio analysis conditions on
the parents’ genotypes and hence is robust to population
stratification bias, the analysis comparing parental ge-
notypes to population-based controls is not (although
Labuda et al. [2002] argue that this may not be an issue
for the particular data they analyze in their report). Fur-
thermore, even when there is no population stratifica-
tion, the latter analysis is something of an “apples and
oranges” comparison, as the exposure of interest is not
the control subject’s genotype, but his or her parent’s
genotype. The control’s genotype serves as a surrogate
for his or her parent’s. In a simulation study with 175
unmatched case and control subjects (1,000 replicates),
we found that the odds ratio comparing case subjects’
maternal genotypes to control genotypes underestimated
the odds ratio associated with each variant maternal
allele by 11% (variant allele frequency 0.25; baseline
probability of disease 14%; odds ratio per variant ma-
ternal allele 2). Of course, the data Labuda et al. (2002)
analyzed did not contain parental genotype information
for the controls. But if one were to design a case-pop-
ulation control study to detect the effects of maternal
(paternal) genotypes, then one should plan to collect
information on controls’ maternal (paternal) genotypes.
Finally, figure 1a is misleading in that case subjects’
parents are not representative of population controls if
individuals’ genotypes are associated with disease or
there is population stratification.
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Regarding “Parental Genotypes in the Risk of a
Complex Disease”
To the Editor:
Labuda et al. (2002) have proposed that parental ge-
notypes might play a role in the causation of complex
diseases. They seem unaware that this idea has been
considered by others (e.g., Lande et al. 1989) and that
methods have been developed to test for parentally me-
diated genetic effects, both for a dichotomous phenotype
(Mitchell 1997; Weinberg et al. 1998; Wilcox et al.
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1998) and for a quantitative phenotype (van den Oord
2000).
Furthermore, some of the assessments made by La-
buda et al. miss the mark. They assume (see their fig. 1)
that under scenario A, where the offspring genotype is
the one that “counts,” the parents of affected children
will resemble control parents with respect to the gene
under study. This ignores the fact that the genotypes of
parents and their children are correlated. Just as the par-
ents of offspring with Huntington disease will differ
from population controls in their prevalence of the allele
for Huntington disease, parents of offspring who have
a complex disease will tend to differ from population
controls. Thus, the case-control analyses reported in ta-
ble 1 of Labuda et al. (2002) are not specific to parentally
mediated genetic effects.
There are other reasons, biologic and technical, to
doubt the interpretation offered by Labuda et al., who
suggest that their data support a parent-mediated effect
of CYP2E1*5 on risk of childhood acute lymphoblastic
leukemia. First, the mechanisms by which the maternal
and paternal genotypes would influence offspring phe-
notype are very different (i.e., in utero environment vs.
DNA replication errors that produce genetically abnor-
mal sperm). It thus seems unlikely that the etiology of
a given condition would be related to both maternal and
paternal effects of a single gene. Rather, similar “effects”
of the maternal and paternal genotypes, on the basis of
case-control parental data, seem more likely due to the
selection of a biased control group or to offspring-me-
diated effects that have confounded the comparison of
the (correlated) parental genotypes. Thus, the data of-
fered by Labuda et al., which show very similar odds
ratios for the mother and for the father, may be seen
more plausibly as reflecting either a systematic bias in
the control group or a chance finding.
The final issue is analytic. The odds ratio parameter
estimated by the case-control analysis is not the same as
that estimated by transmissions. Labuda et al. evidently
used a standard method for paired data, calculating the
ratio of counts for discordant transmission pairs based
on heterozygous parents. This approach estimates the
relative penetrance for carriers of a single copy of the
variant allele under a gene dose model in which the
relative penetrance for two copies is the square of that
for one copy. By contrast, in their case-control analysis,
Labuda et al. use carrier status, which presumes a dom-
inant model. The paired estimator based on transmis-
sions can be shown to be biased toward 1.0 under such
a model. Even if the two analyses were estimating the
same parameter, there is considerable overlap in the CIs
for the two estimates. For these reasons, the results pre-
sented by Labuda et al. (2002) should be seen as pro-
viding only very weak evidence for a parent-mediated
effect of CYP2E1*5.
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Reply to Comments by Kraft and Wilson and by
Weinberg and Mitchell on “Parental Genotypes in the
Risk of a Complex Disease”
To the Editor:
Kraft and Wilson (2002 [in this issue]) point out that
there are other analytical options to a joint application
of case-control and TDT analysis in our study of the
effect of parental genetics in the risk of a complex dis-
ease. They propose a “pseudo-sibling controls” design
as an alternative to the approach proposed earlier by
Weinberg and colleagues (1998) to study parental effects
in case-parent trios. However, these tests are directed to
evaluate the effect within a presumed model and are not
designed to estimate joint effects of both parents’ ge-
notypes, which appeared to be the case with our data.
Our study, inspired by original experimental observa-
tions, led us to understand the underlying genetic effects
